Dear PHD readers,
As you know we’ve been away from the site for a long time building our cancer therapy company, Angiex. Angiex’s drug AGX101 is now in the clinic and we have an exciting story to tell, which will be unfolding on LinkedIn. Please follow the company and help us spread the word. The world needs to know that something special is coming for cancer patients!
I will add LinkedIn posts to this as they come out. Here is what has been published so far:
- Angiex’s vision: No one should die of cancer
- Our founders’ biological discoveries
- Our mission: Create a transformative ADC
To help us, please go to each post and click “Re-post” adding your own thoughts. Thank you!
Please feel free to contact me if you would like to know more about Angiex or think you may be able to help us. The best way to contact me is through the email addresses on the Angiex Contact page. Cancer patients can learn about clinical trial opportunities at our Clinical Trial Q&A page.
Best, Paul
via this link:
Recent Comments